$2 / month

Comment and reply across TML.

Start or manage membership

Most pulsed

Latest from other desks

tml.the modern leap
Health / Public Health

Greenwich Rx Recalls 261 Lots Over Sterility Assurance

The Texas compounding pharmacy pulled compounded sterile products dispensed nationwide between August 10 and September 21, and the FDA says patients should stop using them and throw them away.

TML Health DeskNov 22, 3:20 AM ET · 1 min read
A pharmacy counter (archive). Photo: U.S. Air Force photo by Senior Airman Jessica Sanchez-Chen / Public domain, via Wikimedia Commons.
Summary

No contamination has been found and no illnesses have been reported, and the recall still tells every patient holding these products to stop using them now.

Tap a passage. React to the part that matters.

Greenwich Rx has recalled 261 lots of compounded sterile products nationwide after federal inspectors raised doubts about sterility assurance at its Texas pharmacy.

The recall covers products the Tomball, Texas pharmacy dispensed across the country between August 10 and September 21, 2026. Every lot is still inside its beyond-use date, which means patients may still have these products at home.

The list runs long: compounded semaglutide mixed with B12 or glycine, tirzepatide combinations, and injectables including BPC-157, TB-500, NAD+, glutathione, and sermorelin. Some lots were compounded for another pharmacy, Clove Rx, so a label reading Clove Rx doesn't clear a product.

The company's risk statement is blunt about the stakes. A sterile product that isn't sterile can cause serious infections, and those infections can be life-threatening. So far, the company says, testing hasn't found contamination in any lot, and nobody has reported an adverse event.

The problem surfaced after an FDA inspection of the pharmacy, and Greenwich Rx says its own follow-up evaluation reached the same conclusion. It couldn't assure the sterility of the products, so it's pulling all of them.

Patients holding any of these products should stop using them immediately and discard them, the FDA announcement says. The company is notifying customers by mail, and the full lot list is posted at greenwichrx.org. Questions go to Sedgwick at 888-243-5547, Monday through Friday, 8 a.m. to 5 p.m. Eastern.

Greenwich Rx is a 503A compounding pharmacy, which means it mixes custom medications for individual patients under state pharmacy rules rather than manufacturing drugs through the FDA's approval process. When a compounder can't prove a sterile product is sterile, a recall like this one is the only move available.

The conversation

A little more perspective.

Reading is free. Verified members can comment and reply for $2 a month.

The conversation.

Loading comments…

Keep your curiosity going.

Some links here are affiliate links. If you buy through one, we might make a commission — it never changes what you pay. As an Amazon Associate I earn from qualifying purchases.